반응식
O=C1C2C(=CC=CC=2)C(=O)N1CCN1CCC(C2C=C(NC(=O)C(C)C)C=CC=2)CC1.O=C1C2C(=CC=CC=2)C(=O)[N:34]1[CH2:43][CH2:44][CH2:45][N:46]1[CH2:51][CH2:50][CH:49]([C:52]2[CH:53]=[C:54]([NH:58][C:59](=[O:63])[CH:60](C)C)[CH:55]=[CH:56][CH:57]=2)[CH2:48][CH2:47]1.O=C1C2C(=CC=CC=2)C(=O)N1CCCCN1CCC(C2C=C(NC(=O)C(C)C)C=CC=2)CC1.O=C1C2C(=CC=CC=2)C(=O)N1CCCCCN1CCC(C2C=C(NC(=O)C(C)C)C=CC=2)CC1.O=C1C2C(=CC=CC=2)C(=O)N1CCCCCCN1CCC(C2C=C(NC(=O)C(C)C)C=CC=2)CC1>>[NH2:34][CH2:43][CH2:44][CH2:45][N:46]1[CH2:51][CH2:50][CH:49]([C:52]2[CH:53]=[C:54]([NH:58][C:59](=[O:63])[CH3:60])[CH:55]=[CH:56][CH:57]=2)[CH2:48][CH2:47]1참가 물질
6
반응물 5
생성물 1
실험 절차
Using the methods described above, the following additional intermediates were synthesized. N-(3-{1-[2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHYL]-4-PIPERIDINYL}PHENYL)-2-METHYLPROPANAMIDE. ESMS m/e: 420.2 (M+H)+. N-(3-{1-[3-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)PROPYL]-4-PIPERIDINYL}PHENYL)-2-METHYLPROPANAMIDE: ESMS m/e: 434.4 (M+H)+. N-(3-{1-[4-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)BUTYL]-4-PIPERIDINYL}PHENYL)-2-METHYLPROPANAMIDE: ESMS m/e: 448.4 (M+H)+. N-(3-{1-[5-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)PENTYL]-4-PIPERIDINYL}PHENYL)-2-METHYLPROPANAMIDE. ESMS m/e: 462.4 (M+H)+. N-(3-{1-[6-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)HEXYL]-4-PIPERIDINYL}PHENYL)-2-METHYLPROPANAMIDE: ESMS m/e: 476.4 (M+H)+.
후처리
- customwere synthesized
출처 및 근거
- ORD 기록
- ord-8af05fc719a54c86abcd64157aa15ba4
- 출처 데이터셋
- uspto-grants-2007_04
- 특허 번호
- US07199135B2
연결된 노트
불러오는 중…